Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy Jonestrading

Crinetics Pharmaceuticals Inc
Start price
€39.80
20.03.24 / 50%
Target price
€51.62
20.03.25
Performance (%)
-22.11%
End price
€31.00
21.03.25
Summary
This prediction ended on 21.03.25 with a price of €31.00. The price of Crinetics Pharmaceuticals Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.11%. Jonestrading has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Crinetics Pharmaceuticals Inc 0.659% 0.659% 184.186%
iShares Core DAX® 0,44 % 5,64 % 7,81 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 %
iShares S&P 500 0,37 % 1,92 % 22,34 %

Comments by Jonestrading for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -22.11%
Target price 51.621
Change
Ends at 20.03.25

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Jonestrading from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat

Jonestrading 
0
Report Share
20.03.24
In the thread Trading Crinetics Pharmaceuticals Inc
Prediction Buy
Perf. (%) -22.11%
Target price 51.621
Change
Ends at 20.03.25

Die von Jonestrading gewählte maximale Laufzeit wurde überschritten

Jonestrading 
0
Report Share
21.03.25